Credit Suisse Ag Stevanato Group S.P.A. Transaction History

Credit Suisse Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$25.15 - $32.86 $4.36 Million - $5.7 Million	-173,556 Reduced 80.17%	42,920 $1.39 Million
Q1 2023 May 10, 2023	SELL	$17.5 - $25.9 $1.76 Million - $2.61 Million	-100,593 Reduced 31.73%	216,476 $5.61 Million
Q4 2022 Feb 13, 2023	BUY	$13.95 - $19.28 $241,669 - $334,006	17,324 Added 5.78%	317,069 $5.69 Million
Q3 2022 Nov 10, 2022	SELL	$14.66 - $18.3 $2.4 Million - $3 Million	-163,848 Reduced 35.34%	299,745 $5.08 Million
Q2 2022 Aug 12, 2022	SELL	$14.1 - $20.26 $1.86 Million - $2.68 Million	-132,107 Reduced 22.18%	463,593 $7.33 Million
Q1 2022 May 16, 2022	BUY	$15.23 - $21.47 $18,276 - $25,764	1,200 Added 0.2%	595,700 $12 Million
Q4 2021 Feb 14, 2022	BUY	$21.65 - $27.0 $4.41 Million - $5.5 Million	203,708 Added 52.13%	594,500 $13.3 Million
Q3 2021 Nov 12, 2021	BUY	$19.51 - $28.7 $7.62 Million - $11.2 Million	390,792 New	390,792 $9.89 Million

136

52.8M

1.5K

2.5K

Ticker STVN
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 264,700,000
Market Cap $5.29B
Description
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.